11S REGs (PA28s) are multimeric rings that bind proteasomes and stimulate peptide hydrolysis. Whereas REGa activates proteasomal hydrolysis of peptides with hydrophobic, acidic or basic residues in the P1 position, REGg only activates cleavage after basic residues. We have isolated REGg mutants capable of activating the hydrolysis of¯uorogenic peptides diagnostic for all three active proteasome b subunits. The most robust REGg speci®city mutants involve substitution of Glu or Asp for Lys188. REGg (K188E/D) variants are virtually identical to REGa in proteasome activation but assemble into less stable heptamers/hexamers. Based on the REGa crystal structure, Lys188 of REGg faces the aqueous channel through the heptamer, raising the possibility that REG channels function as substrate-selective gates. However, covalent modi®cation of proteasome chymotrypsinlike subunits by 125 I-YL3-VS demonstrates that REGg (K188E)'s activation of all three proteasome active sites is not due to relaxed gating. We propose that decreased stability of REGg (K188E) heptamers allows them to change conformation upon proteasome binding, thus relieving inhibition of the CT and PGPH sites normally imposed by the wild-type REGg molecule.
Introduction
The proteasome is a large multisubunit protease present in archaebacteria, bacteria and eukaryotes (Bochtler et al., 1999) . Quaternary structures for yeast and Thermoplasma proteasomes were initially obtained by electron microscopy (Dahlmann et al., 1989; Grziwa et al., 1991; Pühler et al., 1992) and more recently by X-ray crystallography (Löwe et al., 1995; Groll et al., 1997) . These structural analyses reveal the proteasome to be a cylindrical particle composed of four stacked rings each containing seven subunits (Bochtler et al., 1999) . The two end rings are composed of a subunits and the two central rings consist of b subunits. All Thermoplasma b subunits are proteolytically active, but only three mammalian b subunits possess the N-terminal threonine needed for peptide cleavage . The proteasome active sites face a large chamber buried in the center of the enzyme (Löwe et al., 1995; Groll et al., 1997) . A 13 Å pore through the a ring of the archaebacterial proteasome connects the external solvent to antechambers that flank the central proteolytic chamber. In the yeast proteasome this narrow pore is occluded by N-terminal sequences from the a subunits, thereby enclosing the internal chambers.
The proteasome's internal chambers are largely inaccessible from the external solvent, yet to be degraded substrates must somehow gain access to the central chamber. Serving this purpose are two protein complexes that bind and activate the proteasome. A regulatory complex containing 18 different subunits (Hoffman et al., 1992; Peters et al., 1993; Udvardy, 1993; DeMartino et al., 1994) associates with the 20S proteasome to produce the 26S proteasome responsible for the energy-dependent degradation of important regulatory proteins via the ubiquitin pathway (Hershko and Ciechanover, 1998; Rechsteiner, 1998; Voges et al., 1999) . The other proteasome activator is a donut-shaped molecule called 11S REG (Dubiel et al., 1992) or PA28 (Ma et al., 1992) . Red blood cell REG is composed of two subunits, REGa and REGb, which are closely related to each other (Ahn et al., 1995; Realini et al., 1997) and to Ki, a major autoantigen in lupus patients (Nikaido et al., 1990) . Recombinant Ki has been shown to activate the proteasome, so it is now called REGg or PA28g . Both REGa and REGg self-associate into oligomeric rings that differ in their ability to activate specific proteasome b subunits. REGa enhances cleavage of peptides with basic, acidic or hydrophobic residues in the P1 position, whereas REGg activates hydrolysis of peptide bonds following basic residues . Although recombinant human REGb is monomeric, high concentrations of this subunit activate the proteasome in a manner similar to REGa Zhang et al., 1998b) . Moreover, REGb readily associates with REGa, forming heteroheptamers that are presumed to be equivalent to the 11S REG molecule isolated from red blood cells (Zhang et al., 1999) .
A crystal structure has been solved for the recombinant REGa heptamer . Each subunit contains four long helices that pack against one another. Mutagenesis studies have shown that the loop connecting helix 2 and helix 3 in the REGa subunit is important for proteasome activation. Thus, residues Arg141-Gly149 are called the activation loop (Zhang et al., 1998a) . The sequences of the REGa and REGg activation loops are identical, so it is unlikely that the activation loop per se Lysine 188 substitutions convert the pattern of proteasome activation by REGg to that of REGs a and b
The EMBO Journal Vol. 20 No. 13 pp. 3359±3369, 2001 ã European Molecular Biology Organization accounts for the fact that REGg only stimulates the proteasome's trypsin-like subunit. For this reason, we asked whether sequences near the activation loop impart the restricted proteasome activation seen with REGg versus broad activation by REGa. Characterization of REG chimeras involving exchange of sequences flanking the activation loops demonstrates that differential proteasome activation is not controlled by the divergent regions surrounding the conserved activation loop (Li and Rechsteiner, 2001) . Although the last eight amino acids in REGa are disordered in the crystal, they originate next to the activation loop and differ in sequence from REGg. Therefore, the C-terminal extensions were examined for their possible role in differential proteasome activation. Characterization of chimeras involving the last 8 or 12 amino acids in REGs a, b and g demonstrated that C-terminal sequences are important for stabilizing REG heptamers and make major contributions to proteasome binding, but they do not affect the activation of specific proteasome subunits (Li et al., 2000) .
In the experiments presented below, random mutagenesis was used to continue the search for REG structural elements controlling the differential activation of the proteasome's catalytic subunits. Single-site mutations involving Lys188 enable REGg to activate all three proteolytic subunits of the proteasome. We propose that proteasome activation by the mutant REGg (K188E) results principally from increased substrate entry, and we attribute the restricted activation by REGg to inhibitory conformational changes in the CT and PGPH subunits imparted by the wild-type proteasome activator.
Results

REGg is a heptamer
Recombinant REGa has been shown to form heptamers by sedimentation , X-ray crystallography and mass spectrometry (MS) (Zhang et al., 1999) . Although REGg has been assumed also to form heptamers based on its elution from a Superdex 200 column , we felt that this assumption should be tested. Accordingly, we sedimented recombinant REGg to equilibrium in a Beckman XL-A Optima analytical ultracentrifuge. Multiple data sets obtained from various speeds and loading concentrations were simultaneously fit to a single species model, returning a molecular weight of 214 T 8 kDa (Figure 1 ). Since the molecular weight of a REGg monomer is 29.5 kDa, these data indicate that there are seven subunits in the REGg oligomer.
Subsequently, we also used electron microscopy to examine the oligomeric state of REGg and REGg (K188E), a mutant capable of activating all three proteasome catalytic subunits (see below). When REGg and REGg (K188E) were examined by negative staining, fields of roundish particles (diameter 11-13 nm) were observed for both samples (Figure 2A and D, respectively). The REGg particles were consistently more uniform in size and appearance than REGg (K188E). In two independent data sets of REGg particles, 7-fold symmetry was detected, most strongly at a radius of 5-5.5 nm, around the outer rim of the particle (Figure 2, table) . No other order of symmetry was found to be statistically significant.
Correlation averaging of these data depicted a 7-fold symmetric particle, with a heavy accumulation of stain at the center surrounded by a thin annulus of protein density and then seven peripheral outcrops ( Figure 2B and C). Thus visualized, REGg is a heptamer with an outer diameter of~13 nm.
As noted, REGg (K188E) particles tended to be less regular in appearance ( Figure 2D ). Nevertheless, from statistical analysis of relatively well preserved molecules, we detected both 7-and 6-fold symmetry as statistically significant (Figure 2, table) , and the data were partitioned accordingly (see Materials and methods). Correlation averaging of the 7-fold data depicted a heptamer that is similar in size and appearance to wild-type REGg ( Figure 2E and F) . The 6-fold data yielded a hexamer that resembles the heptamer apart from its order of symmetry and being slightly smaller. The occurrence of hexamers as well as heptamers in the population of REGg (K188E/D) oligomers correlates with the reduced stability of the mutant oligomers upon gel filtration (Table I) . We note that the hexamer rings may not be completely closed, i.e. there may be a rift between one pair of neighboring subunits, which would tend to enlarge the diameter of this oligomer. Identi®cation of REGg mutants stimulating suc-LLVY-MCA cleavage Random mutagenesis was used previously to identify the REG activation loop (Zhang et al., 1998a) . This approach was modified slightly to screen for REGg molecules capable of activating proteasomal cleavage of suc-LLVY-MCA (see Materials and methods). Four positive colonies were isolated from among 1400 colonies expressing mutagenized REGg plasmids. DNA sequencing identified the four REGg mutants as (L38V, K188N), (F102I, K188N), (L71P, K188E) and K188N. Because each positive variant was mutated at Lys188, we employed site-directed mutagenesis to generate a series of amino acid substitutions at this residue. In all, 12 mutants were constructed in which Lys188 of REGg was changed to Ala, Arg, Asn, Asp, Cys, Gln, Glu, His, Ile, Phe, Pro or Ser. Wild-type REGg and the Lys188 REGg variants were expressed in Escherichia coli, purified, and the activation specificity of each protein was measured using the diagnostic peptides LLVY-MCA, LRR-MCA and LLEbNA. Except for the K188R variant, all Lys188 mutants stimulated the hydrolysis of LRR-MCA by the proteasome to the same extent or slightly better than wild-type REGg (Figure 3 ). With regard to stimulated hydrolysis of LLVY-MCA and LLE-bNA, the single-site variants could be placed, somewhat arbitrarily, into three groups. Substitution of negatively charged Glu or Asp for the positively charged Lys188 produced mutant REGgs with activation properties almost identical to REGa (Table I) . Eight variants clearly stimulated hydrolysis of LLVY-MCA and LLE-bNA, but to extents ranging from 6-fold stimulation exhibited by K188A and K188C to 2-fold stimulation seen with K188I (Table I ). Replacement of Lys188 by Pro or Arg did not enhance cleavage of peptides diagnostic for the CT-like or PGPH active sites of the proteasome. To determine the degree to which the activation specificity of REGg (K188E/D) variants matches that of REGa, proteasomal cleavage of a series of fluorogenic peptides was measured in the presence of each activator. It is clear from the data in Table II that REGg (K188E/D) are virtually identical to REGa in their ability to activate proteasomal hydrolysis of small fluorogenic peptides. (B and C) , the inner ring of density is resolved into seven units whereas REGg (K188E) (E and F) shows this feature as a continuous ring, presumably reflecting the lower resolution of the latter images. Bar, 40 nm (A) and 5 nm (B). Table: a independent data sets from micrographs of different fields of the same grid in each sample; b the spectral ratio product is shown only for the radial zones in which these symmetries were detected most strongly (at a radius of 5 nm). There is some debate as to whether short fluorogenic peptides should be used as diagnostic reagents for determining proteasome cleavage specificity (Ustrell et al., 1995; Groettrup et al., 1996; Tanaka et al., 1997) . For that reason, we also used two natural peptides as proteasome substrates in the presence of REGa, REGg or the two robust REGg specificity mutants (K188E/D). Cleavage products from either a 21-residue peptide (P21) or a 49-residue peptide (BBC1) were separated by HPLC and analyzed by MS. The profiles in Figure 4 , which are representative of samples taken at six different times during the course of the reaction, show that wild-type REGg decreased hydrolysis of P21 by the proteasome. In contrast, REGg (K188E/D) and REGa markedly increased substrate consumption, producing more complicated patterns of cleavage products that are clearly different from the products produced by REGgproteasome complexes. MS analysis provided information on the cleavage sites (compare the open and filled arrows surrounding the sequence of P21 in Figure 4 ).
Somewhat different results were obtained upon hydrolysis of the longer peptide, BBC1. In the absence of proteasome activators, BBC1 was consumed with a halflife of 85 min, producing a series of peptides eluting between 34 and 38 min ( Figure 5 ). With REGg present, degradation was faster (t 1/2 = 65 min), and peptides eluting between 34 and 38 min were largely absent due to their further digestion. The resulting smaller peptides ranged from 2 to 5 amino acids in length and eluted between 20 and 26 min. Substitution of REGa, REGg (K188E) or REGg (K188D) did not markedly alter the spectrum of peptides although these activators did speed BBC1 degradation even more (t 1/2 = 45 min) and produced HPLC profiles that quantitatively, at least, could be distinguished from the REGg profile as shown by the peaks labeled with slanted arrows in Figure 5 . Taken together, assays using two natural peptides provide further evidence that REGg (K188E/D) variants are equivalent to REGa in their activation properties.
Physical properties of REGg Lys188 variants
Previous studies have shown that proteasome activation is affected by the stability of REG heptamers and their affinities for the proteasome (Li et al., 2000) . To examine the effect of Lys188 substitutions on REGg heptamer stability, we rechromatographed wild-type and Lys188 variant heptamers on the Superdex 200 (26/60) size exclusion column used for purification (see Supplementary data, available at The EMBO Journal Online). Wild-type REGg remained fully heptameric, as did REGg (K188H), REGg (K188S), REGg (K188I) and REGg (K188R). Similar analyses showed that the percentage of REGg (K188A), REGg (K188C), REGg (K188N) and REGg (K188Q) that remained heptamers ranged from 60 to 80%, but more than half of the REGg (K188D) and REGg (K188E) heptamers dissociated during the second gel filtration (Table I ). Replacement of Lys188 by Pro or Phe severely affected the stability of REGg heptamers. Approximately 50% of REGg (K188P) heptamers dissociated into monomers while REGg (K188F) variants remained monomers/dimers.
As a measure of the relative affinities of REGg and REGg Lys188 mutants for the proteasome, we employed a competition assay (Li et al., 2000 ; see also Supplementary data). From the summary in Table I it can be seen that all REGg Lys188 mutants were relatively resistant to REGa(N146Y)/REGb(N135Y) competition with apparent proteasome affinities varying from 40 to 90% that of wildtype REGg. The competition assays demonstrate that REGg Lys188 mutants have lower, but comparable affinities for the proteasome, as does wild-type REGg.
The presumed location of REGg Lys188
Based on the fact that REGg is 25% identical to REGa in sequence, we assume that the REGg heptamer adopts a structure similar to that of REGa. In Figure 6 , the hypothetical REGg heptamer is compared with the known crystal structure of REGa. Lys188 resides in the third a-helix of the REGg monomer and presumably faces the aqueous pore through the REGg heptamer. The residue in REGa corresponding to REGg Lys188 is Asp183. It is noteworthy that these two residues are oppositely charged and that the most robust REGg activation specificity mutants (K188E/D) result in charge reversal at this position in helix 3. Comparison of helix 3 residues in REGa and the hypothetical REGg heptamer also identifies other pore-lining residues differing in charge between the two homologs (see residues highlighted in Figure 6 ). To test whether charge differences at these positions might affect the activation specificities of REGg and REGa, sitedirected mutagenesis was used to generate a number of REGa Asp183 point mutants, and two sets of REGa and REGg variants in which the charged, channel-lining residues were exchanged between the homologs. However, none of these mutations changed the activation specificity of the host REG molecules (see Supplementary data).
Af®nity labeling of proteasome b subunits in the presence of REGs There are several possible mechanisms by which REGs a/b and REGg might activate the proteasome differentially. Binding to the proteasome could induce conformational changes in the proteasome's b subunits that alter catalysis. Such changes could, in principle, either increase or decrease catalysis. Alternatively, the REG homologs could open substrate selective channels into the proteasome. To obtain estimates of substrate access to the proteasome's central chamber in the presence of REGg and REGg (K188E), we employed the active site-directed probe, 125 I-YL3-VS, which covalently modifies all three of the active b subunits in an activity-dependent manner (Bogyo et al., 1997 (Bogyo et al., , 1998 . The PhosphorImages presented in Figure 7A show increased labeling of CT/PGPH and T subunits in the presence of REGg or REGg (K188E). The Fig. 4 . HPLC/MS analysis of proteasomal cleavage products from P21. The upper left panel shows the HPLC profile of undigested P21; the remaining panels show the HPLC profiles of cleavage products generated after 12 h at 37°C by 600 ng of proteasome in the absence or presence of REGg, REGa, REGg (K188E) or REGg (K188D). Major cleavage products were identified by MS as described in Materials and methods. Peak 1: the P21 substrate, SADPELALALRVSMEEQRQRQ; peak 2: SADPELALAL; peak 3: RVSMEEQRQRQ; peak 4: SADPELAL; peak 5: SMEEQRQRQ; peak 6: SADPEL; peak 7: ALRV; peak 8: ALAL; peak 3¢: RVSM and RVSME. The undesignated peaks are those products whose sequence could not be unambiguously determined. The filled arrows beneath the P21 sequence reflect the primary cleavage sites by proteasome in the absence or presence of REGg. The downward pointing open arrows are products generated in the presence of REGa or REGg (K188E/D). ; the remaining panels contain profiles of cleavage products generated by the proteasome alone or the proteasome in the presence of REGg, REGa, REGg (K188E) or REGg (K188D). The arrows pointing to the BBC1 sequence identify major cleavage sites by the proteasome alone. The slanted arrows in the HPLC profiles denote cleavage products that are quantitatively distinct between proteasomal degradation in the presence of REGg on one hand and in the presence of REGa or REGg (K188E/D) on the other. Kinetic analyses (data not shown) revealed that the half-life of BBC1 was 85 min in the presence of the proteasome alone, 65 min in the presence of the proteasome plus REGg, and 40 min in the presence of the proteasome and REGg (K188E). Moreover, in each reaction mixture the pattern of cleavage products was essentially the same for samples taken at 10, 30, 135 and 600 min. Aliquots (3 mg) of wild-type REGa, REGg and the two robust REGg specificity mutants, REGg (K188E/D), were mixed with 170 ng of red cell proteasome before the fluorogenic peptides listed above were added to start the reaction. Stimulation is calculated from MCA fluorescence produced by the proteasome in the presence of REGs divided by the fluorescence produced by the proteasome alone. All entries are the averages of three measurements.
initial labeling velocities for each reaction were quantified by graphical analysis of the PhosphorImages ( Figure 7B ), and Figure 7C summarizes the extents to which REGs g and g (K188E) stimulated initial labeling in six independent experiments. These data reveal that REGg increased the rate of T subunit labeling 4.7-fold and the rate of CT/ PGPH labeling 4.4-fold over that seen with the proteasome alone. Stimulation by the mutant REGg (K188E) was greater, being 11-fold for the T subunit and 12-fold for the CT/PGPH subunits. The increased rate of modification induced by REGg (K188E) is roughly comparable to its ability to stimulate sustained hydrolysis of fluorogenic peptides at the three active sites (see Figure 7C versus Table I ). However, the finding that REGg increased labeling of the CT and PGPH subunits was unexpected since the wild-type activator actually suppresses hydrolysis of the CT substrate sLLVY-MCA (Table I) . Nonetheless, it is clear from the results presented in Figure 7 that REGg promoted entry of the hydrophobic, suicide substrate 125 I-YL3-VS to the central chamber of the proteasome. This argues against the possibility that the REGg channel serves as a selective filter and leads us to propose that REGg binding negatively regulates the proteasome's CT/PGPH active sites (see Discussion).
Discussion
REGg (K188E/D) and REGa activate the proteasome almost identically A major finding from the studies presented above is that substitution of Glu or Asp for Lys188 converts the proteasome activation properties of REGg to that of REGa. Several assays demonstrate this essential point. For example, REGa and REGg (K188E/D) activate proteasome hydrolysis of the diagnostic peptides LLVY-MCA, LRR-MCA and LLE-bNA over the same concentration range and to almost the same extent (Figure 3) . Cleavage of each fluorogenic peptide listed in Table II was stimulated almost identically by REGg (K188E/D) and REGa, indicating that the activation specificity of the mutant REGg is virtually equivalent to that of REGa. Analysis of P21 and BBC1 digests (Figures 4 and 5 ) extends equivalent activation by REGg (K188E/D) and REGa to natural peptides as well. Despite the strikingly similar activation properties of REGg (K188E/D) and REGa, the two molecules do not activate the proteasome identically since REGa consistently produces 10-20% more hydrolysis of fluorogenic peptides with hydrophobic residues in the P1 positions ( Figure 3 ; Table II ). 
Lys188 lines the aqueous channel through REGg
Perhaps it is not surprising that amino acid substitutions at a single site, Lys188, change the proteasome activation properties of REGg to those of REGa. However, the apparent location of Lys188 was unexpected. Sequence alignments show that REGg Lys188 corresponds to REGa Asp183, a residue that faces the aqueous channel through the REGa heptamer and is located almost 60 Å from the surface of REGa that binds the proteasome. The assumption that REGg Lys188 and REGa Asp183 occupy equivalent positions is based on the substantial similarities in sequence and structural properties of the two REG homologs as well as on experiments involving site-specific mutations, deletion or exchange of sequences between them. REGa has been shown to be a heptamer by sedimentation , MS (Zhang et al., 1999) and X-ray crystallography . REGg is likewise a heptamer as demonstrated by velocity sedimentation (Figure 1 ) and electron microscopy ( Figure 2 ). REGa and REGg both remain active upon deletion of their homolog-specific inserts (Zhang et al., 1998b) and REGa-g or REGg-a chimeras involving C-terminal sequence exchanges are fully active (Zhang et al., 1998c; Li et al., 2000) . Moreover, three REGg-a variants chimeric for activation loop flanking sequences form heptamers, with two of them being fully active (Li and Rechsteiner, 2001 ). Finally, the activation loops of REGs a and g are identical and specific substitutions in either homolog result in a REG molecule that binds the 
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REGg mutants with REGa activation speci®city proteasome but does not activate it (Zhang et al., 1998a) . Thus, REGs a and g are, for the most part, unaffected by sequence exchanges, and corresponding mutations in each protein produce similar effects. These observations provide strong evidence that REGa and REGg adopt identical folds.
The mechanism of REG activation: selective channels or conformational changes in proteasome b subunits?
The crystal structure of the yeast proteasome shows that a subunit N-terminal sequences form a barrier between the enzyme's internal chambers and the external solvent (Groll et al., 1997) . The crystal structure of REGa reveals a 20-30 Å -wide aqueous channel through a donut-shaped heptamer , and electron microscopic images suggest that REG heptamers bind the proteasome with their aqueous channels normal to and centered over the proteasome a subunit ring (Gray et al., 1994) . This led to the proposal that REG binding would displace proteasome a subunit N-terminal sequences opening a continuous channel to the enzyme's central proteolytic chamber . A crystal structure of the yeast proteasome complexed with a Trypanosoma REG (PA26) has recently been solved and in fact, a continuous channel does exist from the upper surface of REG to the proteasome's central catalytic chamber (Whitby et al., 2000) . Thus, there is little doubt that REG binding creates a channel through which substrates and products should exchange more readily between the external solvent and the enzyme's buried catalytic sites. In principle, formation of a continuous channel could account for the broad activation of peptide hydrolysis by REG a and b molecules (Groll et al., 2000; Whitby et al., 2000) . To explain the differential activation by REGs a/b and g, however, it is necessary to propose that either REG channels act as selective filters or REGg binding inhibits catalysis by the CT and PGPH active sites. The location of Lys188 on the channel surface and the dramatic effects of reversing its charge by substitution of Asp or Glu would seem to support the idea that REG channels function as selective filters. However, we do not favor this hypothesis for several reasons. First, proteasomal cleavage of small fluorogenic tripeptides of comparable dimensions, AAF-MCA, LLE-bNA and LRR-MCA, is affected to markedly different extents by REGg and REGg (K188E/D) (Table II) . Secondly, if our structural model for REGg is correct, a ring of positive charge at the entrance to the REGg channel ( Figure 6 ) should present a barrier to the diffusion of positively charged, fluorogenic peptides into the proteasome. Yet these are the very substrates whose hydrolysis is stimulated by REGg (Table II) .
Two experimental findings pose more direct problems for the selective channel model. It is apparent from the HPLC profiles in Figure 5 that the BBC1 peptide was fully consumed by the proteasome with or without added REGs. If REGs simply increase entry of BBC1 into the proteasome, one would expect the same set of products in the presence or absence of REGs; the products would just appear sooner. The increased frequency of multiple cleavages in BBC1 indicates that REGs expand the number of peptide bonds susceptible to hydrolysis by the proteasome once BBC1 enters the central proteolytic chamber. There are two mechanisms by which this could occur. REGs could activate or change the specificity of proteasome b subunits, thereby increasing the probability of multiple cleavages in BBC1. Or REGs could slow the exit of initial BBC1 cleavage products thereby promoting further cleavages (Dolenc et al., 1998) . The latter possibility is inconsistent with the fact that REGg and g (K188E) speed destruction of BBC1 (see Results) presumably by promoting entry of the peptide to the proteasome's central chamber.
Secondly, use of 125 I-YL3-VS clearly demonstrates that REGg does not exclude hydrophobic peptides since the wild-type proteasome activator increased b subunit modification almost 5-fold (Figure 7) . Labeling by 125 I-YL3-VS requires the compound to enter the proteasome's central chamber, bind to b subunit active sites and form a covalent bond to the N-terminal threonines. The initial labeling rate is a composite of these three steps so we can not strictly conclude that REGg promotes 125 I-YL3-VS entry. It could, in principle, speed either or both of the latter two steps. Still, given the recent finding that binding of PA26 or deletion of proteasome a subunit sequences activates all three b subunits (Groll et al., 2000; Whitby et al., 2000) , it is very likely that REGg opens a non-selective channel into the proteasome.
Initial labeling of proteasome b subunits in the presence of REGg (K188E) is 2.3-or 3-fold faster than in the presence of REGg ( Figure 7C ). For the T site, this difference approximates the slightly greater ability of REGg (K188E) to increase cleavage of LRR-MCA (Table I) . However, the 3-fold greater CT/PGPH labeling by REGg (K188E) relative to REGg is an order of magnitude lower than its ability to stimulate sustained cleavage of sLLVY-MCA by the CT site. The complete proteolytic reaction requires two additional steps besides substrate entry, binding and covalent bond formation. The covalent adduct to the N-terminal threonine of active b subunits must be hydrolyzed and the product released. We propose that at the T site these two steps proceed at similar rates when either REGg or REGg (K188E) is bound; however, at the CT site they are 10-fold slower in the presence of REGg. That is, REGg inhibits hydrolysis of the tetrahedral intermediate and/or product release from the CT site. Alternatively, REGg (K188E) stimulates one or both of these steps (see Table III ).
The following considerations strongly favor inhibition by REGg. First, it is clear from the hydrolysis of fluorogenic peptides that REGg does inhibit the CT and PGPH activities (Table II) . Secondly, Groll et al. (2000) have recently shown that removing N-terminal sequences from the a3 subunit of the yeast 20S proteasome stimulates hydrolysis of LLE-bNA by 10-fold and hydrolysis of LRR-MCA or LLVY-MCA by 20-fold. Their results are in good agreement with the enhanced hydrolysis of the very same peptides induced by REGg (K188E) as shown in Table II . Since removing a3 N-terminal sequences opens a gate to the central chamber (Groll et al., 2000) , it seems reasonable to interpret the stimulation by REGg (K188E) mainly in terms of increased substrate access. Stohwasser et al. (2000) came to much the same conclusion from recent kinetic analyses of proteasome activation by REG homologs. If increased catalysis of LRR-MCA reflects gate opening by REGg-(K188E) and REGg, it follows that REGg must inhibit catalysis at the CT and PGPH active sites.
Proposed mechanism for differential proteasome activation by REGs REGg (K188E/D) differ from wild-type REGg in an important physical property; they are less stable heptamers. In fact, they appear to form hexamers as well as heptamers (Figure 2) . We suspect that this may be the very property that prevents REGg (K188E/D) from inhibiting the CT and PGPH active sites. Our hypothesis is based on the data in Table I , where, with two exceptions (K188P and K188F), a trend is present between the heptamer instability of Lys188 variants and activation of LLVY-MCA and LLE-bNA hydrolysis (see Supplementary data). We assume that REG-proteasome interaction involves conformational adjustments that could take place either in the REG heptamers or in the proteasome or most likely in both. We speculate that wild-type REGg subunits bind each other so tightly that they resist conformational adjustment upon association with the proteasome. As a consequence most changes occur within the proteasome, and some of these conformational adjustments inhibit the CT and PGPH subunits. In contrast, when REGg (K188E) binds, adjustments occur both in the bound REG and in the proteasome. As a result, the CT and PGPH subunits remain active (see Figure 8) . For reasons unknown, the T-like subunit escapes inhibition by REGg. However, it is clearly affected upon REGg and REGg (K188E/D) binding, as shown by the HPLC patterns in Figure 5 . All REGs, a, g and gK188E/D, induced additional cleavages in BBC1, and these are likely to result from altered specificity of the T subunit, since BBC1 is such a basic peptide. In summary, the experiments presented above illustrate two important features of the proteasome activators known as 11S REG or PA28. First, a single amino acid change converts the activation specificity of REGg to that of REGs a and b. Substitution of Glu or Asp for REGg Lys188 is attended by a decrease in heptamer stability, and this may Table I ). The affinity labeling assay using 125 I-YL3-VS is only diagnostic for the first three steps, where REGg (K188E) is 2.3-and 3-fold more efficient than REGg in stimulating the labeling of T and CT subunits, respectively (calculated from Figure 7C ). The marked difference (wild type versus mutant) between their stimulation of catalysis by the CT subunit and their stimulation in CT labeling suggests that REGg and REGg (K188E) have markedly differential effects on the last two steps, hydrolysis and product release, at the CT/PGPH sites. Fig. 8 . A model for differential proteasome activation by REG proteins. The yeast 20S proteasome (Groll et al., 1997) and human 11S REGa are altered to illustrate the REG-proteasome interaction. The three catalytic b subunits are marked with asterisks and labeled. In this model, we propose that the REG-proteasome interaction involves conformational adjustments in both the REG heptamers and the proteasome (shown as arrows). The wild-type REGg heptamer is rigid so that conformational adjustments occur only within the proteasome, and these conformational changes inhibit the CT and PGPH subunits (left, shown as smaller asterisks 
Materials and methods
Construction of an expression library encoding random REGg mutants Error-prone PCR was used to introduce random mutations into the REGg cDNA (Zhang et al., 1998a) . The PCR products were inserted into pET26(b) through NdeI-BamHI sites. The resulting plasmid library was transformed into BL21(DE3) cells. Approximately 60% of the isolated colonies contained a single-site mutation.
Isolation of REGg mutants stimulating the chymotrypsin-like activity of the proteasome Transformants were picked and grown at 37°C in LB containing 25 mg/ml kanamycin. Protein expression was induced with 0.8 mM isopropylb-D-thiogalactopyranoside for 2 h at 30°C. Cells were collected by centrifugation and lysed with 10 mM Tris-HCl pH 7.5, 0.5% Triton X-100 and 0.3 mg/ml polymixin B sulfate. Aliquots were incubated with 170 ng of proteasome and 100 mM LLVY-MCA. After a 10 min incubation, reactions were terminated with 200 ml of ethanol and fluorescence was measured as described (Li et al., 2000) . Highly active colonies were rescreened as above and plasmids were then purified and sequenced.
Site-directed mutagenesis Oligonucleotide-directed mutagenesis was used to introduce point mutations into REGs a or g as described (Zhang et al., 1998a) . All constructs were sequenced to confirm the absence of unintended mutations.
Puri®cation of REG mutants and determination of their activation speci®city REG mutants were expressed and purified to homogeneity as described (Li et al., 2000) . Each REG protein (3 mg) was mixed with 170 ng of proteasome and 100 mM substrate (LLVY-MCA, LRR-MCA or LLEbNA) to measure their activation specificity as described (Li et al., 2000) .
Digestion of natural synthetic peptides
Proteasomal hydrolysis of P21 and BBC1 peptides was carried out as described (Zhang et al., 1998b) . Digestion products were applied to a C18 HPLC column and separated with a gradient of 0-45% acetonitrile containing 0.1% trifluoroacetic acid. To identify the products derived from P21, fractions were collected manually, concentrated, and subjected to MS.
Equilibrium sedimentation
Sedimentation equilibrium was used to assess the solution states of wildtype and chimeric REGg proteins as recently described (Li et al., 2000) . Briefly, samples ranging in concentration from 27.5 to 110 mg/ml were centrifuged at 20°C at speeds ranging from 11 000 to 13 000 r.p.m. until sedimentation and chemical equilibria were attained. Data were collected by radial scanning of the centrifuge cell with 10 absorbance measurements at 280 nm taken every 0.001 cm. Values of 0.741 ml/g for the partial specific volume and 1.016 g/ml for the solvent density were used.
Electron microscopy Grids bearing carbon-coated nitrocellulose films were glow-discharged prior to being floated for 2 min on 10 ml drops of sample at a protein concentration of 30 mg/ml. The sample drop was then blotted away, and the grid was negatively stained by floating on a drop of 1% uranyl acetate for 10 s. Specimens were observed in a Philips EM400T transmission electron microscope, and micrographs were recorded at a nominal magnification of 46 000Q. Details of the image analysis are presented as Supplementary data.
Active site af®nity labeling Purified human red blood cell proteasomes (1 mg) were diluted into 100 ml of reaction buffer (50 mM Tris pH 7.4, 5 mM MgCl 2 , 2 mM dithiothreitol). Purified recombinant REGg and REGg (K188E) were diluted to a final concentration of 20 mg/ml from a 1 mg/ml stock solution into the buffer containing proteasomes, and the mixture was incubated for 10 min at 37°C to induce complex formation. The radiolabeled probe, 125 I-YL3-VS, was then added (~10 6 c.p.m.), the reactions were incubated at room temperature for 5, 10, 15, 30, 60 and 120 min, and quenched by addition of one-fourth volume of 4Q SDS sample buffer. Samples were analyzed by SDS-PAGE (12.5%) and the resulting gels fixed, dried and exposed to a PhosphorImaging screen (Molecular Dynamics). Bands of activity corresponding to the T-like subunit and combination of CT and PGPH subunits (both run as a single band and can not be resolved) were quantitated using the ImageQuant software (Molecular Dynamics).
Supplementary data
Supplementary data for this paper are available at The EMBO Journal Online.
